Key result
Losartan and ferrostatin-1 reverse ferroptosis-driven basilar artery dilation impairment caused by Angiotensin II in hypertensive rats.
Why the study?
The mechanism by which Angiotensin II impairs nitrergic vasodilation and triggers ferroptosis in cerebral arteries remains unclear.
Does Angiotensin II impair neurogenic nitrergic dilation in basilar arteries of rats?
Does Angiotensin II impair neurogenic nitrergic dilation in basilar arteries of rats?
Angiotensin II induces functional alterations in neurovascular signaling by triggering ferroptosis within nerve terminals, impairing neurogenic nitrergic dilation in basilar arteries of hypertensive rats.
Answers are grounded in this paper and cite their sources.
Should not yet change practice in hypertensive cerebrovascular disease; extends animal evidence on Ang II but remains hypothesis-generating for humans.
Background/Objectives: The renin–angiotensin–aldosterone (RAA) system is a key regulator of cardiovascular homeostasis. Recent evidence suggests that Angiotensin II (Ang II) can trigger ferroptosis, an iron-dependent form of cell death. We previously demonstrated that periodontitis induces neurovascular dysfunction, and our preliminary observations indicate that this oral inflammatory model is associated with elevated blood pressure. However, the mechanism by which Ang II impaired nitrergic vasodilation and triggered ferroptosis in cerebral arteries remains unclear. This study investigates the functional effects of electrical and chemical nerve stimulation in adult spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY). Methods: Endothelium-denuded basilar arterial (BA) rings from SHRs and WKYs were used to assess the impact of Ang II on neurogenic relaxation via wire myography. Results: Vascular relaxation responses to nicotine and transmural nerve stimulation (TNS) were significantly diminished in SHRs compared to WKYs. This impairment was reversed by both acute preincubation and chronic treatment with losartan (an AT1 receptor antagonist). In WKY BAs, exogenous Ang II pretreatment inhibited relaxation responses to nicotine, TNS, and isoproterenol. Importantly, this inhibition was effectively reversed by marimastat (MMP inhibitor), catalase (antioxidant), and ferrostatin-1 (ferroptosis inhibitor). Conclusions: Our findings indicate that Ang II induces functional alterations in neurovascular signaling patterns by triggering ferroptosis within nerve terminals. This process leads to a functional imbalance between sympathetic and parasympathetic influences, ultimately impairing neurogenic nitrergic dilation in the BAs of SHRs. These results suggest that targeting Ang II-induced ferroptosis may alleviate the neuroinflammation and cognitive decline associated with hypertension-related cerebrovascular dysfunction.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied Hypertension. Angiotensin II and Losartan vs. Wistar-Kyoto rats (WKY) control was evaluated on Vascular relaxation responses to nicotine and transmural nerve stimulation. Angiotensin II impaired neurogenic nitrergic dilation in the basilar arteries of hypertensive rats by triggering ferroptosis, which was reversed by losartan and ferrostatin-1.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: